News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Robert A. Vogel, MD

Articles by Robert A. Vogel, MD

Clinical Implications of Recent Cholesterol Lowering Trials for the Secondary Prevention of Coronary Heart Disease

ByRobert A. Vogel, MD

March 1st 1997

Lack of Intensive Treatment of CHD Risk Factors: Could the Physician Be the Most Important Risk Factor?

ByRobert A. Vogel, MD

March 1st 1997

Latest Updated Articles

Clinical Implications of Recent Cholesterol Lowering Trials for the Secondary Prevention of Coronary Heart Disease
Published: March 1st 1997 | Updated:
Lack of Intensive Treatment of CHD Risk Factors: Could the Physician Be the Most Important Risk Factor?
Published: March 1st 1997 | Updated:

Trending on AJMC

FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss

FDA Approves Aficamten for Obstructive Hypertrophic Cardiomyopathy

ICYMI: Highlights From ASCO 2025

AI Ultrasound Models Show High Accuracy in Ovarian Cancer Diagnosis

HEDIS Glycemic Goal Achieved Using Control-IQ Technology

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.